New Study Tests Early 'Blockade' to Reduce Prostate Cancer Recurrence
September 23, 2005
Leslie Oleksowicz, MD, will lead the first study of chemotherapy plus targeted anti-tumor therapy as an early approach to prostate cancer treatment. She wants to determine whether early, aggressive treatment of prostate cancer can delay or prevent tumor recurrence, ultimately increasing patient survival rates.